AGM/EGMApr 29, 2026, 08:16 AM
ATHE General Meeting to vote on 50:1 share consolidation
AI Summary
Alterity Therapeutics will hold a General Meeting online on May 29, 2026, to vote on several key resolutions. These include the election of two directors, a 50:1 consolidation of issued capital for both shares and options, and the approval to issue options to Director Julian Babarczy and an entity associated with Director Lawrence Gozlan. Shareholders will also vote on amending the company's constitution to increase the issue cap for its employee incentive plan to 10% and approve the issuance of up to 1,087,541,633 securities under the plan.
Key Highlights
- General Meeting scheduled for May 29, 2026, at 12 pm AEST.
- Shareholders to vote on a 50:1 consolidation of issued capital for shares and options.
- Election of Mr. Julian Babarczy and Ms. Ann Cunningham as Directors.
- Approval to issue up to 100,000,000 pre-Consolidation options to Director Julian Babarczy.
- Approval to issue up to 50,000,000 pre-Consolidation options to Montoya Pty Ltd ATF Buttercup Trust.
- Amendment to Constitution to set employee incentive plan issue cap at 10% of issued capital.
- Approval to issue up to 1,087,541,633 pre-Consolidation securities under an incentive plan.